Floatation therapy may be a novel treatment for anorexia nervosa

A trailblazing study conducted by researchers at the Laureate Institute for Brain Research (LIBR) in Tulsa, Okla., has made significant strides with a novel technique for treating anorexia nervosa (AN), an eating disorder characterized by low body weight, body image abnormalities, and anxiety.

Investors advocate for early biotech partnerships for later deal success – Pharmaceutical Technology

Share this article Companies need to consider the long-term market value of their therapies and analyse the reimbursement landscape while considering deals early in the

April 23, 2024

Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy

HAMBURG, Germany — A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed.

October 6, 2023

FDA Shoots Down Needle-Free EpiPen Alternative, Requests More Data

The FDA declined to approve an epinephrine nasal spray (ARS-1, also known as neffy), requesting that an additional premarketing study be conducted, maker ARS Pharmaceuticals

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.